Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells by nantkweststg | Jan 28, 2021
Targeting PD-L1 With Chimeric Antigen Receptor Modified NK Cells Induces Tumor Control and Reduction of PD-L1 High Immune Populations by nantkweststg | Jan 28, 2021
Engineered killer immune cells target tumours and their immunosuppressive allies by nantkweststg | Jan 28, 2020
Recent Comments